Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of BIIB074 (Raxatrigine) in Neuropathic Pain
2015-004775-78Phase 2Completed
- Sponsor
- Biogen
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vixotrigine in Neuralgia (3 arms), sponsored by Biogen. Started Mar 2016; status: completed.
02
Drugs
vixotrigine
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2015-004775-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004775-78.